Stina Singel
Chief Tech/Sci/R&D Officer chez ASCENDIS PHARMA A/S
Fortune : 412 543 $ au 31/03/2024
Profil
Stina Singel's career history includes current and former positions as well as education.
Currently, Dr. Singel is the Executive VP & Head-Clinical Development at Ascendis Pharma A.
Previously, Dr. Singel worked as the Senior Medical Director at Genentech, Inc. from 2014 to 2019 and as the SVP, Head-Clinical Development & Drug Safety at Nektar Therapeutics from 2019 to 2020.
Dr. Singel holds a doctorate degree from The Salk Institute for Biological Studies and the University of California San Diego, as well as an undergraduate degree from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0,01% | 31/12/2023 | 2 729 ( 0,01% ) | 412 543 $ | 31/03/2024 |
Postes actifs de Stina Singel
| Sociétés | Poste | Début |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 01/05/2020 |
Anciens postes connus de Stina Singel
| Sociétés | Poste | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/05/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
Formation de Stina Singel
| The Salk Institute for Biological Studies | Doctorate Degree |
| Harvard University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
